Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-049820

Options or other derivatives

  • Director acquired 0 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chambers Michael Andrew · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-09-13 Grant or award : show line 1 in the form Convertible Senior Notes +0 $20,000,000.00 $0 I
Loading xslF345X03/doc4.xml…